Literature DB >> 32471937

What do differences in case fatality ratios between children and adults tell us about COVID-19?

Fabio Midulla1, Luca Cristiani2, Enrica Mancino2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32471937      PMCID: PMC7257617          DOI: 10.1183/13993003.01852-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
From the authors: We thank S. Ebmeier and A.J. Cunnington for their commentary on our editorial [1], providing another point of view on such a controversial topic. In their letter, S. Ebmeier and A.J. Cunnington assume that the greater burden of coronavirus disease 19 (COVID-19) in adults may be related to the absence in the population of prior immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as occurred in fully susceptible populations during previous viral epidemics. In particular, Shanks et al. [2] report that the measles mortality rate in a fully susceptible population during the 1846 measles epidemic was higher in adults and in children aged <2 years. However, nowadays, children younger than 5 years and adults older than 20 years are still more likely to suffer from measles complications, despite not being fully susceptible [3]. Moreover, Strebel et al. [4] reported that the case fatality ratio is still high in children aged <1 year, lower in children aged 1–9 years, and then rises again in teenagers and adults. The reported data suggest that greater morbidity and mortality in adults is not a unique feature of first-contact measles epidemics. As regards West Nile virus infection [5], severe fever with thrombocytopenia syndrome [6] and Plasmodium falciparum malaria [7], several factors such as pathogen features, transmission dynamics and population characteristics could be potential confounders; therefore, we think that these diseases may not be comparable to COVID-19. Moreover, Lindsey et al. [5] and Li et al. [6] described higher mortality rates in adults, but data were collected over several years and we are not sure that the populations can be considered fully susceptible over time. Furthermore, the SARS-CoV-2 viral genome is 75–80% identical to the SARS-CoV virus that caused a global pandemic in 2002–2003 [8]. Human coronavirus infections are very common worldwide [9-11]. Recently, Grifoni et al. [12] analysed adaptive immunity to SARS-CoV-2 and detected SARS-CoV-2-reactive CD4+ T-cells in ∼40–60% of unexposed individuals, suggesting a cross-reactive T-cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2. In view of these overall considerations, we can speculate that SARS-CoV-2 infection may not have spread in a fully susceptible population. This hypothesis may be also confirmed by a previous study by Fedson [13], which reported that the different age-related mortality during the 1918 influenza pandemic could be related to previous exposures to the H1N1-like viruses, suggesting a fundamental role of “antigenic imprinting” on individual response. In conclusion, we are more likely to consider that other reasons, rather than absence of prior immunity, could play a crucial role in the dilemma regarding children and the coronavirus. This one-page PDF can be shared freely online. Shareable PDF ERJ-01852-2020.Shareable
  11 in total

1.  Surveillance for human West Nile virus disease - United States, 1999-2008.

Authors:  Nicole P Lindsey; J Erin Staples; Jennifer A Lehman; Marc Fischer
Journal:  MMWR Surveill Summ       Date:  2010-04-02

2.  Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study.

Authors:  Hao Li; Qing-Bin Lu; Bo Xing; Shao-Fei Zhang; Kun Liu; Juan Du; Xiao-Kun Li; Ning Cui; Zhen-Dong Yang; Li-Yuan Wang; Jian-Gong Hu; Wu-Chun Cao; Wei Liu
Journal:  Lancet Infect Dis       Date:  2018-07-24       Impact factor: 25.071

3.  Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum.

Authors:  Geoffrey J Gorse; Gira B Patel; Joseph N Vitale; Theresa Z O'Connor
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

4.  Age-specific measles mortality during the late 19th-early 20th centuries.

Authors:  G D Shanks; M Waller; H Briem; M Gottfredsson
Journal:  Epidemiol Infect       Date:  2015-04-13       Impact factor: 4.434

5.  Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study.

Authors:  Anna M Checkley; Adrian Smith; Valerie Smith; Marie Blaze; David Bradley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2012-03-27

6.  Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population.

Authors:  Litty Varghese; Philip Zachariah; Celibell Vargas; Philip LaRussa; Ryan T Demmer; Yoko E Furuya; Susan Whittier; Carrie Reed; Melissa S Stockwell; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

7.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

8.  A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020.

Authors:  Enrica Mancino; Luca Cristiani; Alessandra Pierangeli; Carolina Scagnolari; Raffaella Nenna; Laura Petrarca; Greta Di Mattia; Domenico La Regina; Antonella Frassanito; Giuseppe Oliveto; Agnese Viscido; Fabio Midulla
Journal:  J Clin Virol       Date:  2020-04-29       Impact factor: 3.168

Review 9.  Influenza, evolution, and the next pandemic.

Authors:  David S Fedson
Journal:  Evol Med Public Health       Date:  2018-10-03

10.  Will children reveal their secret? The coronavirus dilemma.

Authors:  Luca Cristiani; Enrica Mancino; Luigi Matera; Raffaella Nenna; Alessandra Pierangeli; Carolina Scagnolari; Fabio Midulla
Journal:  Eur Respir J       Date:  2020-04-23       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.